Now, Libtayo (cemiplimab) is also in the mix. Sanofi and Regeneron have just halted a 466-patient phase 3 trial of the drug in combination with chemo rarely, saying they saw a significant ...

The indication is based on a phase 3 trial – Empower-Lung 1 – that showed Libtayo given as a monotherapy cut the risk of death by 43% compared to chemotherapy in advanced, PD-L1-high patients ...

Libtayo sales are being driven by growth in demand for non-melanoma skin indications, coupled with increased utilization in both monotherapy and chemotherapy combination settings in lung cancer.

Biotech giant Regeneron Pharmaceuticals, Inc. REGN is slated to report first-quarter 2025 results on April 29, 2025. The ...

Patients with pathologically confirmed solid tumors were treated with ICIs consisting of anti-PD-1/PD-L1 blockade (nivolumab [Opdivo], pembrolizumab [Keytruda], atezolizumab [Tecentriq], cemiplimab ...

Since announcing she had finished chemotherapy last September, Kate Middleton has gradually returned to public engagements. And now it has been announced that next week she and Prince William will ...

But post chemotherapy he has been able to work on his physical fitness and is feeling better for it. He said he has refused to ‘google’ his condition but asked a friend to find out who has ...

A 12-minute virtual reality session during chemotherapy reduced heart rate, stress and pain compared with standard care. Most patients reported high satisfaction and no cybersickness with the ...

Months after sharing she was cancer free after a private battle with breast cancer, "The Office" alum gave fans an update on her hair growth journey after completing chemotherapy. "I am borderline ...

MONDAY, April 21, 2025 (HealthDay News) -- An oral chemotherapy drug can safely and effectively manage sickle cell disease in children, a new study says. Children taking hydroxyurea had fewer ER ...